Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2328-2331

  Schoen, Christoph ^a   Unzicker, Christian ^a   Stuhler, Gernot ^a   Elias, Johannes ^a   Einsele, Hermann ^a   Grigoleit, Götz Ulrich ^a   Abele Horn, Marianne ^a   Mielke, Stephan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CEFTAZIDIME; CIPROFLOXACIN; CLOFARABINE; CYCLOPHOSPHAMIDE; DAPTOMYCIN; FOSFOMYCIN; MEROPENEM; POSACONAZOLE; TIGECYCLINE; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTION; CORYNEBACTERIUM JEIKEIUM; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCAL INFECTION; FECES ANALYSIS; HUMAN; LOADING DRUG DOSE; MALE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CORD BLOOD STEM CELL TRANSPLANTATION; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; DAPTOMYCIN; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

CORYNEBACTERIUM JEIKEIUM; POSIBACTERIA;

EID: 67650087604     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00457-09     Document Type: Article

References (20)

1. Abele-Horn, M., U. Vogel, I. Klare, C. Konstabel, R. Trabold, R. Kurihara, W. Witte, W. Kreth, P. G. Schlegel, and H. Claus. 2006. Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci. J. Clin. Microbiol. 44:4009-4013.
2. Appelbaum, P. C., and M. R. Jacobs. 2005. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria. Curr. Opin. Microbiol. 8:510-517.
3. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
4. Elvy, J., D. Porter, and E. Brown. 2008. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J. Antimicrob. Chemother. 61:461-462.
5. Friedman, L., J. D. Alder, and J. A. Silverman. 2006. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:2137-2145.
6. Funke, G., and K. A. Bernhard. 2007. Coryneform gram-positive rods, p. 485-514. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
7. Funke, G., A. von Graevenitz, J. E. Clarridge III, and K. A. Bernard. 1997. Clinical microbiology of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.
8. Goldstein, E. J., D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. T. Fernandez. 2004. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. Antimicrob. Agents Chemother. 48:2149-2152.
9. Hutter, G., U. Schlagenhauf, G. Valenza, M. Horn, S. Burgemeister, H. Claus, and U. Vogel. 2003. Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens. Microbiology 149:67-75.
10. Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
11. Kvirikadze, N., M. Suseno, T. Vescio, L. Kaminer, and K. Singh. 2006. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia. Scand. J. Infect. Dis. 38:290-292.
12. Montero, C. I., F. Stock, and P. R. Murray. 2008. Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob. Agents Chemother. 52:1167-1170.
13. Munoz-Price, L. S., K. Lolans, and J. P. Quinn. 2005. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin. Infect. Dis. 41:565-566.
14. Skiest, D. J. 2006. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J. Clin. Microbiol. 44:655-656.
15. Steenbergen, J. N., J. Alder, G. M. Thorne, and F. P. Tally. 2005. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 55:283-288.
16. Stefani, S., and P. E. Varaldo. 2003. Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9:1179-1186.
17. Streit, J. M., R. N. Jones, and H. S. Sader. 2004. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms. J. Antimicrob. Chemother. 53:669-674.
18. Tauch, A., O. Kaiser, T. Hain, A. Goesmann, B. Weisshaar, A. Albersmeier, T. Bekel, N. Bischoff, I. Brune, T. Chakraborty, J. Kalinowski, F. Meyer, O. Rupp, S. Schneiker, P. Viehoever, and A. Puhler. 2005. Complete genome sequence and analysis of the multiresistant nosocomial pathogen Corynebacterium jeikeium K411, a lipid-requiring bacterium of the human skin flora. J. Bacteriol. 187:4671-4682.
19. Traub, W. H., U. Geipel, B. Leonhard, and D. Bauer. 1998. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium. Chemotherapy 44:230-237.
20. Van der Auwera, P. 1989. Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin. Antimicrob. Agents Chemother. 33:1783-1790.